Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER

Dementia

Washington University School of Medicinemonoclonal_antibodyPhase 2/3Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
31/ 100
Competitive Position
81/ 100

Competitive context

43 Active assets in the Dementia cohort.

Asset / SponsorPhaseRating
Risperdal
Hannover Medical School
Phase 4BBB
CITALOPRAM
Hannover Medical School
Phase 4BBB
Cipralex
Ohio State University
Phase 4BB
Galantamine Hydrobromide
Janssen Pharmaceutica N.V., Belgium
Phase 3BB
Namenda
Zealand University Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER is also rated in:

Alzheimer diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
familial Alzheimer diseaseDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →